Further observations on the effect of ethyl-α-p-chlorophenoxyisobutyrate + androsterone (Atromid) on plasma fibrinogen and serum cholesterol in patients with ischaemic heart disease
- 2 January 1966
- journal article
- research article
- Published by Elsevier in Journal of Atherosclerosis Research
- Vol. 6 (1), 98-102
- https://doi.org/10.1016/s0368-1319(66)80064-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The effect of Atromid-S on the fibrinolytic enzyme systemJournal of Atherosclerosis Research, 1965
- Fibrinolytic Activity and Thyroid FunctionBMJ, 1965
- The Effect of Atromid on Plasma Fibrinogen and Heparin ResistanceJournal of Atherosclerosis Research, 1963
- Multicentre trial in the united kingdom and ireland of a mixture of ethyl chlorophenoxyisobutyrate and androsterone (atromid)Journal of Atherosclerosis Research, 1963
- The effects of atromid on serum cholesterol, serum triglycerides, and radioactive fat tolerance in patients with hyperlipidemia. a preliminary reportJournal of Atherosclerosis Research, 1963
- REDUCTION OF SERUM-LIPID AND URIC-ACID LEVELS BY AN ORALLY ACTIVE ANDROSTERONEThe Lancet, 1962
- Relation of plasma fibrinogen concentration changes to human arteriosclerosisJournal of Applied Physiology, 1961